Biocon Biologics clears path for U.S. launch of denosumab biosimilars Bosaya and Aukelso
Settlement with Amgen enables commercialisation of Bosaya and Aukelso in the United States from October 1, 2025
Author
Pfizer signs agreement with Trump Administration to lower U.S. drug prices and boost…
The agreement covers drug pricing parity, patient discounts through TrumpRx.gov, and a $70 billion U.S. investment commitment
Lupin receives US FDA approval for Rivaroxaban for oral suspension
Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug…
Innovation has been at the heart of our growth journey
Sekhar Surabhi, CEO & Founder, Caliber Technologies and Director, ISPE India Affiliate, Chair, ISPE Pharma 4.0, Community of…
Saroj G. Warke receives “Women Empowerment Principles Leadership 2025” Award
Saroj G. Warke, Co-founder and IT Director of HiMedia Laboratories has received the prestigious “Women Empowerment Principles…
Inaugural edition of PCG 2025 marks milestone in India’s pharma innovation journey
The inaugural edition of the Peptides & Complex Generics Symposium (PCG 2025), jointly organised by the Mumbai Biocluster and…
CDSCO clarifies regulatory pathway for combi-pack approvals of Lyophilized injections &…
The Central Drugs Standard Control Organization (CDSCO) has issued a clarification concerning the regulatory approval process for…
Novo Nordisk to launch Ozempic in India, sets stage for GLP-1 market expansion
With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…
Ayush Ministry inaugurates first integrative oncology research and care centre at AIIA Goa
The Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda…
Lupin acquires VISUfarma to strengthen ophthalmology business
Lupin’s wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V.…